MedPath

Pharmaceutical Companies

Ownership
-
Established
-
Employees
-
Market Cap
$3.2B
Website
-

Olink Holding AB

🇸🇪Sweden
Ownership
-
Established
-
Employees
707
Market Cap
$3.2B
Website
-
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of...
VIRBAC SA logo

VIRBAC SA

🇵🇹Portugal
Ownership
Public
Established
1968-01-01
Employees
5.4K
Market Cap
$3.1B
Website
http://www.virbac.fr
KYMERA THERAPEUTICS INC logo

KYMERA THERAPEUTICS INC

🇺🇸United States
Ownership
Public
Established
2017-01-01
Employees
187
Market Cap
$3.1B
Website
http://www.kymeratx.com

BAVARIAN NORDIC

🇩🇰Denmark
Ownership
-
Established
1992-01-01
Employees
759
Market Cap
$3.1B
Website
http://www.bavarian-nordic.com
Ownership
-
Established
1996-01-01
Employees
-
Market Cap
$3.1B
Website
http://www.xenon-pharma.com/
SpringWorks Therapeutics logo

SpringWorks Therapeutics

🇺🇸United States
Ownership
Public
Established
2017-01-01
Employees
305
Market Cap
$3B
Website
http://www.springworkstx.com
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat,...
Arrowhead Pharmaceuticals logo

Arrowhead Pharmaceuticals

🇺🇸United States
Ownership
Public
Established
1989-01-01
Employees
525
Market Cap
$2.9B
Website
http://www.arrowheadpharma.com
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include...

Hutchmed Limited

🇨🇳China
Ownership
-
Established
-
Employees
-
Market Cap
$2.9B
Website
-

MoonLake Immunotherapeutics

🇨🇭Switzerland
Ownership
Public
Established
-
Employees
50
Market Cap
$2.9B
Website
http://www.moonlaketx.com
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian...
© Copyright 2025. All Rights Reserved by MedPath